Search people, articles, bills, and more
Voters should care about this bill because sickle cell disease is a serious genetic blood disorder affecting hundreds of thousands of Americans, predominantly those of African, Hispanic, and South Asian descent. Currently, there isn't a complete national picture of how many people have it, who they are, or how they use healthcare, which makes it harder to develop effective treatments, policies, and support services. If this bill becomes law, having better, standardized data could help researchers find new cures, improve access to specialized care, and ensure resources are directed where they are most needed.
Without this bill, the understanding of sickle cell disease in the U.S. would remain fragmented, potentially leading to gaps in care, underfunded research, and missed opportunities to support affected communities. The reinstatement of specific CDC employees also aims to restore expertise in blood disorders within a key public health agency, which could impact the agency's ability to address various blood-related health issues.
No reactions yet. Be the first to weigh in.
Voters should care about this bill because sickle cell disease is a serious genetic blood disorder affecting hundreds of thousands of Americans, predominantly those of African, Hispanic, and South Asian descent. Currently, there isn't a complete national picture of how many people have it, who they are, or how they use healthcare, which makes it harder to develop effective treatments, policies, and support services. If this bill becomes law, having better, standardized data could help researchers find new cures, improve access to specialized care, and ensure resources are directed where they are most needed.
Without this bill, the understanding of sickle cell disease in the U.S. would remain fragmented, potentially leading to gaps in care, underfunded research, and missed opportunities to support affected communities. The reinstatement of specific CDC employees also aims to restore expertise in blood disorders within a key public health agency, which could impact the agency's ability to address various blood-related health issues.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| AMOUNT | PROGRAM | TYPE | YEARS |
|---|---|---|---|
| $10,000,000 | Sickle Cell Data Collection program | discretionary | Fiscal years 2027 through 2031 |